DelMar Pharmaceuticals completes direct public offering

On April 13, cancer company DelMar Pharmaceuticals Inc. (NASDAQ:DMPI) raised $9 million through the sale of 2.8 million shares at $3.25 in a registered direct offering. H.C. Wainwright was the placeme...